Literature DB >> 24442494

Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan.

Shih-Wei Lai1, Kuan-Fu Liao, Cheng-Li Lin, Fung-Chang Sung.   

Abstract

This study investigated whether an association exists between irritable bowel syndrome (IBS) and the risk of Parkinson's disease. This is a retrospective cohort study using the dataset of the Taiwan National Health Insurance Program from 2000 to 2010. We identified 23,875 patients (aged 20 years or older) with newly diagnosed IBS as the IBS group and 95,500 subjects without IBS as the non-IBS group for comparison. The main outcome was incident Parkinson's disease compared between both groups by the end of 2010. We measured the hazard ratio (HR) to evaluate the association between IBS and Parkinson's disease. The overall incidence of Parkinson's disease in the IBS group was 1.76-fold higher than that in the non-IBS group (16.4 vs. 9.33 per 10,000 person-years). The multivariable Cox proportional hazards regression analysis revealed that the adjusted HR of Parkinson's disease associated with IBS was 1.48 (95% CI 1.27, 1.72), compared with the non-IBS group. Age, women, hypertension, dementia, cerebrovascular disease and depression were also significantly associated with Parkinson's disease. Patients with irritable bowel syndrome are at an increased risk of developing Parkinson's disease. Further studies are required to explore the pathophysiological connection between these disorders.

Entities:  

Mesh:

Year:  2014        PMID: 24442494     DOI: 10.1007/s10654-014-9878-3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

Review 1.  Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.

Authors:  Maria G Cersosimo; Eduardo E Benarroch
Journal:  Neurobiol Dis       Date:  2011-10-25       Impact factor: 5.996

Review 2.  Parallel manifestations of neuropathologies in the enteric and central nervous systems.

Authors:  G Natale; L Pasquali; A Paparelli; F Fornai
Journal:  Neurogastroenterol Motil       Date:  2011-09-26       Impact factor: 3.598

3.  Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: a population-based study.

Authors:  Shih-Wei Lai; Li-Ting Su; Chih-Hsueh Lin; Chon-Haw Tsai; Fung-Chang Sung; Dennis Paul Hsientang Hsieh
Journal:  Psychogeriatrics       Date:  2011-09       Impact factor: 2.440

Review 4.  New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

Authors:  L Ohman; M Simrén
Journal:  Dig Liver Dis       Date:  2007-01-30       Impact factor: 4.088

5.  Multifarious terminology: multivariable or multivariate? univariable or univariate?

Authors:  Tim J Peters
Journal:  Paediatr Perinat Epidemiol       Date:  2008-11       Impact factor: 3.980

6.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

Authors:  Rebecca M Lovell; Alexander C Ford
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-15       Impact factor: 11.382

7.  Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.

Authors:  Shih-Wei Lai; Pei-Chun Chen; Kuan-Fu Liao; Chih-Hsin Muo; Cheng-Chieh Lin; Fung-Chang Sung
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

8.  A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease.

Authors:  Hélène Pouclet; Thibaud Lebouvier; Emmanuel Coron; Stanislas Bruley des Varannes; Tiphaine Rouaud; Monica Roy; Michel Neunlist; Pascal Derkinderen
Journal:  Neurobiol Dis       Date:  2011-08-22       Impact factor: 5.996

9.  Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Chien-Chang Liao; Chih-Hsin Muo; Chiu-Shong Liu; Fung-Chang Sung
Journal:  Medicine (Baltimore)       Date:  2010-09       Impact factor: 1.889

Review 10.  Non-motor symptoms in Parkinson's disease.

Authors:  W Poewe
Journal:  Eur J Neurol       Date:  2008-04       Impact factor: 6.089

View more
  33 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome.

Authors:  S Mahurkar; C Polytarchou; D Iliopoulos; C Pothoulakis; E A Mayer; L Chang
Journal:  Neurogastroenterol Motil       Date:  2015-12-16       Impact factor: 3.598

Review 3.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

4.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

5.  Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Authors:  Madelyn C Houser; Jianjun Chang; Stewart A Factor; Eric S Molho; Cyrus P Zabetian; Erin M Hill-Burns; Haydeh Payami; Vicki S Hertzberg; Malú G Tansey
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

6.  Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.

Authors:  Yuki Kishimoto; Wandi Zhu; Waki Hosoda; Jyoti M Sen; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2019-05-11       Impact factor: 3.843

7.  Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-10-01       Impact factor: 2.953

Review 8.  Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection.

Authors:  Geert R D'Haens; Christian Jobin
Journal:  Gastroenterology       Date:  2019-06-17       Impact factor: 22.682

9.  Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study.

Authors:  Tuomas H Mertsalmi; Anna But; Eero Pekkonen; Filip Scheperjans
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

10.  Irritable bowel syndrome and subsequent risk of Parkinson's disease: a nationwide population-based matched-cohort study.

Authors:  Mun Kyung Sunwoo; Yong Wook Kim; Seo Yeon Yoon; Jaeyong Shin; Seok-Jae Heo; Jee Suk Chang
Journal:  J Neurol       Date:  2021-07-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.